Pharm Sci. 2022;28(1): 122-129.
doi: 10.34172/PS.2021.33

Scopus ID: 85127173709
  Abstract View: 466
  PDF Download: 424

Research Article

Effects of Transcutol P and Precirol ATO-5 on Percutaneous Absorption of Flutamide from Emulgels

Parandis Khalilollah 1,2 ORCID logo, Javad Shokri 3,4 ORCID logo, Seyedehzahra Ahmadi 2 ORCID logo, Farnaz Monajjemzadeh 5,1,4* ORCID logo

1 National Institute for Medical Research Development, Tehran, Iran.
2 Student Research Committee, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
3 Dermatology and Dermopharmacy Research Team, Tabriz University of Medical Sciences, Tabriz, Iran.
4 Faculty of Pharmacy, Tabriz University of Medical sciences, Tabriz, Iran.
5 Food and Drug Safety Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
*Corresponding Author: Email: Monajjemzadehf@yahoo.com


Background: Flutamide is a non-steroidal anti-androgenic agent which is not only used in treating prostate cancer but also can be effective in some disorders such as androgenic alopecia and male pattern baldness. Several serious side effects for systemic administration of flutamide can be overcome by emulgel dosage form. Absorption enhancers can promote permeation of flutamide through skin. Percutaneous absorption of Flutamide emulgels with different concentrations of Transcutol P and Precirol ATO5 was studied.

Methods: Various emulgel formulations using different concentration of Transcutol P and Precirol ATO5 with 0.5 to 5 % w/w were prepared. Percutaneous absorption was tested with standard Franz Diffusion Cell equipment using full thickness rat skin. Drug concentrations in the samples were analyzed by High-Performance Liquid Chromatography (HPLC) equipped with UV-Vis detector at 305 nm.

Results: The percutaneous absorption of flutamide emulgels formulated with enhancers was higher than control formulations. Enhancement ratio increased from 1.218 to 3.670 and 1.346 to3.900 for Precirol ATO5 and Transcutol P, respectively. Area under the Curve (AUC) increased by increase the enhancers’ concentration and a significant upsurge was seen in the concentration 1% for both enhancers.

Conclusion: The flutamide emulgel containing 1% Transcutol P showed more appropriate percutaneous absorption through the skin compared to others.

First Name
Last Name
Email Address
Security code

Abstract View: 467

Your browser does not support the canvas element.

PDF Download: 424

Your browser does not support the canvas element.

Submitted: 27 Mar 2021
Revision: 14 Jun 2021
Accepted: 15 Jun 2021
ePublished: 26 Jun 2021
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)